相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease
Alexander Storch et al.
NEUROLOGY (2013)
Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/DeltaFosB expression
Fernando Eduardo Padovan-Neto et al.
NEUROSCIENCE LETTERS (2013)
The Pharmacology of L-DOPA-Induced Dyskinesia in Parkinson's Disease
Philippe Huot et al.
PHARMACOLOGICAL REVIEWS (2013)
The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias
Christopher A. Lieu et al.
BRAIN RESEARCH BULLETIN (2012)
Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats
Kazuhiro Takuma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Does unilateral basal ganglia activity functionally influence the contralateral side? What we can learn from STN stimulation in patients with Parkinson's disease
Yohann Brun et al.
JOURNAL OF NEUROPHYSIOLOGY (2012)
L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: Insights into regulation and function
Isabel Espadas et al.
NEUROBIOLOGY OF DISEASE (2012)
Nitric Oxide Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinson's Disease and Other Motor Disorders
Massimo Pierucci et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2011)
Role of Nitric Oxide in Motor Control: Implications for Parkinson's Disease Pathophysiology and Treatment
Elaine Del-Bel et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation
Mahmoud M. Iravani et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions
Trevor Archer et al.
NEUROTOXICITY RESEARCH (2011)
Dyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeys
Christopher A. Lieu et al.
PARKINSONISM & RELATED DISORDERS (2011)
Striatal plasticity in Parkinson's disease and L-DOPA induced dyskinesia
M.M. Iravani et al.
PARKINSONISM & RELATED DISORDERS (2011)
Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in rats
N. Novaretti et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2010)
Kisspeptin Regulates Prolactin Release through Hypothalamic Dopaminergic Neurons
Raphael E. Szawka et al.
ENDOCRINOLOGY (2010)
l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia
Hanna S. Lindgren et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Striatal Overexpression of ΔFosB Reproduces Chronic Levodopa-Induced Involuntary Movements
Xuebing Cao et al.
JOURNAL OF NEUROSCIENCE (2010)
Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery
E. A. Del-Bel et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Mechanisms compensating for dopamine loss in early Parkinson disease
Jonathan Brotchie et al.
NEUROLOGY (2009)
NITRIC OXIDE SYNTHASE INHIBITION ATTENUATES L-DOPA-INDUCED DYSKINESIAS IN A RODENT MODEL OF PARKINSON'S DISEASE
F. E. Padova-Neto et al.
NEUROSCIENCE (2009)
Rodent models of treatment-induced motor complications in Parkinson's disease
M. Angela Cenci et al.
PARKINSONISM & RELATED DISORDERS (2009)
Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia
Joohyung Lee et al.
BRAIN (2008)
A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway
Margarete Zanardo Gomes et al.
BRAIN RESEARCH (2008)
Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats
Laura E. Bianco et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Molecular mechanisms of L-DOPA-induced dyskinesia
Peter Jenner
NATURE REVIEWS NEUROSCIENCE (2008)
In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole
Bobby Thomas et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice
M. B. Echeverry et al.
PSYCHOPHARMACOLOGY (2007)
Changes in brain functional activation during resting and locomotor states after unilateral nigrostriatal damage in rats
J. Yang et al.
NEUROIMAGE (2007)
The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice
M. Chalimoniuk et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
The 6-hydroxydopamine model of Parkinson's disease
Nicola Simola et al.
NEUROTOXICITY RESEARCH (2007)
Clinical correlates of levodopa-induced dopamine release in Parkinson disease - A PET study
N. Pavese et al.
NEUROLOGY (2006)
Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys
Christian Pifl et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracelullar striatal dopamine
Wassilios Meissner et al.
NEUROBIOLOGY OF DISEASE (2006)
The therapeutic potential of monoamine oxidase inhibitors
MBH Youdim et al.
NATURE REVIEWS NEUROSCIENCE (2006)
ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice
N Pavon et al.
BIOLOGICAL PSYCHIATRY (2006)
Role of nitric oxide on motor behavior
EA Del Bel et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2005)
Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion
ZC Xu et al.
BRAIN RESEARCH (2005)
How does Parkinson's disease begin? The role of compensatory mechanisms
JA Obeso et al.
TRENDS IN NEUROSCIENCES (2004)
Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats
EA Del Bel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Pergolide mesylate, a dopaminergic receptor agonist, applied with L-DOPA enhances serum antioxidant enzyme activity in Parkinson disease
M Chalimoniuk et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease:: implications for dyskinesias
R de la Fuente-Fernández et al.
BRAIN (2004)
Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off
AH Rajput et al.
PARKINSONISM & RELATED DISORDERS (2004)
'Passive stabilization' of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat
BP Bergstrom et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Inhibition of neuronal nitric oxide synthase increases dopamine efflux from rat striatum
MT Silva et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated
E Bezard et al.
TRENDS IN NEUROSCIENCES (2003)
Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications
F Calon et al.
MOVEMENT DISORDERS (2003)
Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity?
MJ Zigmond et al.
PARKINSONISM & RELATED DISORDERS (2002)
Regulation of striatal dopamine neurotransmission by nitric oxide: Effector pathways and signaling mechanisms
AR West et al.
SYNAPSE (2002)
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease
M Lundblad et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Sodium nitroprusside stimulates L-DOPA release from striatal tissue through nitric oxide and cGMP
JJ Sanchez et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat
N Jonkers et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
Bromocriptine markedly suppresses levodopa-induced abnormal increase of dopamine turnover in the parkinsonian striatum
N Ogawa et al.
NEUROCHEMICAL RESEARCH (2000)
Axonal sprouting following lesions of the rat substantia nigra
DI Finkelstein et al.
NEUROSCIENCE (2000)
The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP+ accumulation
A Boireau et al.
NEUROPHARMACOLOGY (2000)
分享论文
